Skip to main content

A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors.

Publication ,  Conference
Ernstoff, MS; Ma, WW; Tsai, FY-C; Munster, PN; Zhang, T; Kamoun, W; Pipas, JM; Chen, S; Santillana, S; Askoxylakis, V
Published in: Journal of Clinical Oncology
May 20, 2018

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

TPS2604 / TPS2604

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ernstoff, M. S., Ma, W. W., Tsai, F.-C., Munster, P. N., Zhang, T., Kamoun, W., … Askoxylakis, V. (2018). A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors. In Journal of Clinical Oncology (Vol. 36, pp. TPS2604–TPS2604). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.tps2604
Ernstoff, Marc S., Wen Wee Ma, Frank Yung-Chin Tsai, Pamela N. Munster, Tian Zhang, Walid Kamoun, J Marc Pipas, Sharon Chen, Sergio Santillana, and Vasileios Askoxylakis. “A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors.” In Journal of Clinical Oncology, 36:TPS2604–TPS2604. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.tps2604.
Ernstoff MS, Ma WW, Tsai FY-C, Munster PN, Zhang T, Kamoun W, et al. A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. TPS2604–TPS2604.
Ernstoff, Marc S., et al. “A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors.Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. TPS2604–TPS2604. Crossref, doi:10.1200/jco.2018.36.15_suppl.tps2604.
Ernstoff MS, Ma WW, Tsai FY-C, Munster PN, Zhang T, Kamoun W, Pipas JM, Chen S, Santillana S, Askoxylakis V. A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. TPS2604–TPS2604.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

TPS2604 / TPS2604

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences